StockWatch
·
Specialty Chemicals
Open Offer21 Jul 2026, 09:30 pm

Anupam Rasayan launches ₹299/share open offer for Bliss GVS Pharma

AI Summary

Anupam Rasayan India Limited, along with its person acting in concert (PAC), Mates Visa Consultancy Private Limited, has submitted a Letter of Offer for an open offer to acquire fully paid-up equity shares of Bliss GVS Pharma Limited. The offer is to acquire up to 2,77,26,848 equity shares, representing 26.00% of the expanded voting share capital of Bliss GVS Pharma. The offer price is ₹299.00 per equity share. This open offer is being made in compliance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company has also stated that this is not a conditional or competing offer and does not require a minimum level of acceptance. Non-resident shareholders will need to obtain necessary approvals.

Key Highlights

  • Anupam Rasayan launches open offer for Bliss GVS Pharma shares.
  • Offer price set at ₹299 per share.
  • Acquisition targets 26% of expanded voting share capital.
  • Offer complies with SEBI (SAST) Regulations, 2011.
  • No minimum acceptance condition for the offer.